Big Law

Gilead and US Government Settle HIV Drug Patent Case

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead’s HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.

The settlement follows a victory for Gilead in a 2023 jury trial on the government’s patent infringement allegations.

Gilead General Counsel Deborah Telman said in a statement that the agreement “allows Gilead to continue to focus its resources on its mission to discover, develop, and deliver innovative therapeutics to people with life-threatening diseases.”

Read more at Reuters.

Back to top button